Clinical Trials List
2011-04-01 - 2013-12-31
Phase III
Terminated2
ICD-10H35.051
Retinal neovascularization, unspecified, right eye
ICD-10H35.052
Retinal neovascularization, unspecified, left eye
ICD-10H35.053
Retinal neovascularization, unspecified, bilateral
ICD-10H35.059
Retinal neovascularization, unspecified, unspecified eye
ICD-9362.16
Retinal neovascularization NOS
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- An-Fei Li Division of Ophthalmology
- Shih-Jen Chen Division of Ophthalmology
- 楊昌叔 Division of Ophthalmology
- 林伯剛 Division of Ophthalmology
- 劉怜瑛 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wei-Chi WU Division of Ophthalmology
- 趙安年 Division of Ophthalmology
- 陳墩祿 Division of Ophthalmology
- 王南凱 Division of Ophthalmology
- Yih-Shiou Hwang Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
120 participants
